Amerigo Scientific Introduces the Launch of Polystreptavidin 350
Amerigo Scientific now introduces Polystreptavidin 350 for applications in lateral flow, ELISA or CLIA.
- (1888PressRelease) March 21, 2022 - Amerigo Scientific, a distribution company focused on providing critical products and services to the biomedical and life science research communities, now introduces Polystreptavidin 350 for applications in lateral flow, ELISA or CLIA.
Diagnosis is a key enabler of universal health coverage and the first line of defense against the spread of many diseases. From rapid treatment and combating antimicrobial resistance, to providing personalized medicine, the need for clinical diagnostics, especially in vitro diagnostics, continues to expand. The development of new diagnostics generates value not only in the diagnostic tests themselves, but also in downstream care pathways. Tests for new biomarkers that use new analytical techniques are developed to enable faster, more sensitive and more specific disease diagnosis, thereby improving patient outcomes and reducing healthcare costs.
Amerigo Scientific partners with global diagnostic manufacturers to provide a broad, broad portfolio of clinical diagnostics products to simplify workflows and improve operational efficiency. The product portfolio includes FDA or CE approved in vitro diagnostic kits, basic biological raw materials, and automated instruments and reagents for clinical chemistry, hematology and immunology.
At Amerigo Scientific, essential biological raw materials are provided to the diagnostics and research industries based on ethical considerations and customer-specific requirements. These high quality products include a range of antigen products, normal human serum, disease state plasma, standards, positive control materials, and reagents for diagnostic tests such as buffers, catalysts, cofactors, blockers, substrates, stabilizers agents and solvents.
Amerigo Scientific now offers new Polystreptavidin 350 for global researchers for application in lateral flow, ELISA or CLIA. Streptavidin is a tetrameric protein (4 x 13 kDa) that binds very tightly to the small molecule biotin. The binding constant for this interaction is very high (Ka ~ 1013 M-1) and makes the streptavidin/biotin system the basis for many biochemical applications. Streptavidin-coated surfaces are characterized by very low nonspecific binding.
"With a professional team, Amerigo Scientific can provide you with high-quality Polystreptavidin 350 and other conjugates that can be optimized to meet your unique quality control requirements. Our experienced scientists work directly with you to deliver reliable and reproducible results for your studies. Amerigo Scientific is always here to support your research." said Nina Cooper, Ph.D., the chief scientist at Amerigo Scientific.
For more information about the Polystreptavidin 350 or any other detail about Amerigo Scientific's clinical diagnostics products, please visit https://www.amerigoscientific.com.
About Amerigo Scientific
Amerigo Scientific is a distribution company that focuses on providing critical products and services to the biomedical and life science research communities. Although it is a new company, Amerigo Scientific's founder has had more than 20 years of rich experience in the biomedical and biochemical fields, and has established close contacts with key personnel in top international pharmaceutical and biotech companies, academic research institutes, and government research agencies. It has a professional team, as most of its employees own a graduate (Ph.D. or master) degree in life science, so they can understand customers' questions or concerns and are always ready to provide individualized customer service with high standard.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam